Biochem-Peptides
At Biochem Peptides, we are more than just a supplier—we are a family-driven business fueled by a deep passion for peptide therapies. With over five years of dedicated research into the potential and benefits of peptides, our journey led us to establish Biochem Peptides in 2025, built upon a foundation of personal discovery and scientific exploration.
Our commitment extends beyond providing high-quality research chemicals and peptides; we strive to advance understanding and innovation in the field. We believe in the transformative possibilities of peptide therapies, empowering researchers and professionals to explore new frontiers in enhanced living.
At the heart of Biochem Peptides are our core values: trust, loyalty, and respect. These principles guide every aspect of our business, from sourcing premium-grade compounds to fostering long-term relationships with our customers. We are dedicated to transparency, reliability, and ethical practices, ensuring that every interaction upholds the highest standards of integrity.
Biochem Peptides is more than a company—it is a vision for a future where scientific discovery and personal wellness converge.
Tirzepatide 40mg (Lyophilized Vial)
🧬 Tirzepatide – Dual Incretin Receptor Agonist (GLP-1 + GIP) Synonyms: LY3298176 CAS Number: 2023788-19-2 Sequence: C₂₂₅H₃₄₃N₆₅O₆₈ Molecular Weight: 4817.48 g/mol Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Tirzepatide is a synthetic 39-amino acid peptide analog engineered for the investigation of dual incretin receptor pathways, exhibiting high affinity toward both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Designed for enhanced metabolic stability, extended half-life, and potent receptor engagement, Tirzepatide is a prominent research candidate in the study of glucose regulation, satiety signaling, and energy homeostasis. --- ⚙️ Mechanism of Action: Tirzepatide functions as a dual agonist of the GLP-1 and GIP receptors, initiating a multifaceted cascade of metabolic activities: • GLP-1R Activation: Enhances glucose-stimulated insulin secretion, suppresses glucagon, delays gastric emptying. • GIPR Activation: Synergizes insulinotropic action and contributes to lipid metabolism and energy balance. • Integrated Signaling: Modulates hypothalamic appetite pathways and supports insulin sensitivity in peripheral tissues. This dual-receptor engagement mimics and amplifies endogenous incretin effects, making it a unique scaffold for studying multi-axis metabolic modulation. --- 📈 Research Applications: Tirzepatide is of significant interest in preclinical models focused on: • Obesity and appetite suppression • Type 2 diabetes and glycemic control • Insulin resistance and beta-cell preservation • Lipid metabolism and cardiovascular markers Its extended duration of action and receptor selectivity make it suitable for long-term observational protocols. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Recommended storage: –20°C (dry conditions) • Reconstitute using bacteriostatic water, acetic acid, or appropriate research-grade diluent • store in the refrigerator once a reconstituted solution to maintain integrity 2-8 °C
£130.00
Retatrutide 20mg (Lyophilized Vial)
🧬 Retatrutide – Triple Receptor Agonist (GLP-1 + GIP + Glucagon) Synonyms: LY3437943 CAS Number: 2768074-01-5 Sequence: C₂₈₄H₄₅₂N₇₈O₈₅ Molecular Weight: ~6,000 Da (approximate) Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Retatrutide is a next-generation synthetic peptide designed as a tri-agonist targeting three key metabolic receptors: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor). This multi-receptor engagement positions Retatrutide at the forefront of research into energy homeostasis, adiposity modulation, and glycemic regulation. --- ⚙️ Mechanism of Action: Retatrutide’s triple agonist profile initiates a coordinated metabolic response: • GLP-1R Activation: Enhances insulin secretion, suppresses glucagon, delays gastric emptying • GIPR Activation: Amplifies insulinotropic effects and supports lipid metabolism • GCGR Activation: Promotes energy expenditure via hepatic and adipose tissue pathways This integrated signaling cascade is under investigation for its potential to reduce caloric intake, increase thermogenesis, and improve insulin sensitivity in preclinical models. --- 📈 Research Applications: Retatrutide is being explored in metabolic research for its potential to: • Modulate body weight and adiposity • Improve glucose tolerance and insulin dynamics • Influence lipid profiles and hepatic fat content • Support multi-axis endocrine regulation Its tri-receptor activity offers a unique scaffold for studying combinatorial incretin and glucagon signaling in metabolic disease models. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C in a desiccated environment • Reconstitute with bacteriostatic water, acetic acid, or other suitable diluent • store in a refrigerator once a reconstituted solution to maintain stability 2-8 °C
£130.00
AOD-9604 10mg (Lyophilized Vial)
🧬 AOD-9604 – Modified hGH Fragment (176–191) for Lipolytic Research Synonyms: Anti-Obesity Drug 9604, hGH Frag 176–191, Tyr-hGH(176–191) CAS Number: 221231-10-3 Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Weight: ~1,814 Da Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: AOD-9604 is a synthetic peptide fragment derived from the C-terminal region (176–191) of human growth hormone (hGH), specifically engineered to retain the lipolytic (fat-burning) properties of hGH without its anabolic or diabetogenic effects. By isolating this bioactive domain and adding a tyrosine residue at the N-terminus, AOD-9604 exhibits enhanced metabolic stability and receptor selectivity, making it a compelling candidate in adipose tissue metabolism research. --- ⚙️ Mechanism of Action: AOD-9604 is believed to exert its effects through: • Stimulation of lipolysis: Promotes breakdown of stored triglycerides in adipocytes • Inhibition of lipogenesis: Reduces conversion of non-fat substrates into fat • Selective action on adipose tissue: Minimal impact on muscle growth or IGF-1 levels Unlike full-length hGH, AOD-9604 does not stimulate insulin resistance or linear growth, making it a focused tool for studying fat metabolism without systemic endocrine disruption A. --- 📈 Research Applications: AOD-9604 is under investigation in preclinical models for: • Obesity and adiposity modulation • Targeted fat reduction protocols • Metabolic syndrome and lipid regulation • Synergistic use with GLP-1 analogs (e.g., Semaglutide) in combination studies Its unique mechanism makes it suitable for localized fat metabolism studies and non-anabolic metabolic modulation. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C in a desiccated, light-protected environment • Reconstitute with bacteriostatic water or acetic acid as appropriate • store in the refrigerator once a reconstituted solution to preserve bioactivity 2-8°C
£50.00
SLU-PP-332 5mg (Lyophilized Vial)
🧬 SLU-PP-332 – Exercise-Mimetic Peptide for Metabolic & Regenerative Research Synonyms: Pan-ERR Agonist, Exercise-Mimetic Peptide CAS Number: N/A (investigational compound) Molecular Formula: Proprietary Molecular Weight: ~1.2–3.5 kDa (estimated range) Form: Lyophilized powder or sublingual tablet (varies by supplier) Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- 📖 Description: SLU-PP-332 is a synthetic peptide-like compound developed at Saint Louis University, designed to activate estrogen-related receptors (ERRα/β/γ)—key regulators of mitochondrial biogenesis, fatty acid oxidation, and energy metabolism. It is under active investigation as a non-hormonal exercise mimetic, with potential applications in metabolic health, muscle regeneration, and anti-inflammatory modulation. Unlike traditional stimulants or hormonal agents, SLU-PP-332 mimics the molecular effects of aerobic exercise without requiring physical exertion, making it a promising candidate for obesity, sarcopenia, and metabolic syndrome research. --- ⚙️ Mechanism of Action: SLU-PP-332 acts as a pan-ERR agonist, particularly targeting ERRα, to induce exercise-like adaptations: • Mitochondrial Biogenesis: Increases mitochondrial density and respiratory efficiency • Fatty Acid Oxidation: Enhances lipid metabolism and thermogenesis • Muscle Fiber Remodeling: Promotes oxidative Type I/IIa fiber expression • Anti-Inflammatory Effects: Downregulates TNF-α and IL-6 in metabolic tissues • Circadian Modulation: Activates REV-ERB pathways for metabolic rhythm alignment • Cardioprotection: Improves ejection fraction and reduces cardiac fibrosis in preclinical models --- 📈 Research Applications: SLU-PP-332 is being explored in preclinical and in vitro models for: • Obesity & Fat Loss: Reduces adiposity without altering food intake • Exercise Performance: Increases endurance capacity and VO₂ max in animal models • Muscle Recovery: Enhances satellite cell activation and muscle fiber repair • Metabolic Syndrome: Improves insulin sensitivity and glucose tolerance • Cardiovascular Health: Supports mitochondrial function in cardiac tissue • Neuroinflammation: Investigated for mitochondrial support in CNS models Its non-stimulant, non-hormonal profile makes it suitable for long-term metabolic and regenerative research. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide or sublingual tablet • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water or appropriate buffer (if in powder form) • For sublingual tablets: store in a cool, dry place • Stable for up to 14 days at 2–8°C
£35.00
Cagrilintide 10mg (Lyophilized Vial)
🧬 Cagrilintide – Long-Acting Amylin & Calcitonin Receptor Agonist (DACRA) Synonyms: AM833, NNC0174-0833 CAS Number: 2768074-01-5 Sequence: C₂₈₄H₄₃₀N₇₈O₈₄ Molecular Weight: ~5,800–6,000 Da (approximate) Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Cagrilintide is a synthetic peptide analog of human amylin, engineered to act as a dual amylin and calcitonin receptor agonist (DACRA). It is structurally optimized for enhanced receptor binding, metabolic stability, and reduced fibrillogenicity. Cagrilintide is under active investigation for its role in appetite regulation, gastric motility, and glucagon suppression, making it a compelling candidate in the study of obesity, type 2 diabetes, and energy balance. --- ⚙️ Mechanism of Action: Cagrilintide exerts its effects through coordinated activation of: • Amylin Receptors: Modulates postprandial glucagon secretion, slows gastric emptying, and enhances satiety signaling • Calcitonin Receptors: Contributes to appetite suppression and may influence glucose and lipid metabolism Its long-acting profile allows for sustained receptor engagement, supporting extended observation windows in metabolic research models. --- 📈 Research Applications: Cagrilintide is being explored in preclinical settings for its potential to: • Reduce caloric intake and body weight • Improve glycemic control and insulin sensitivity • Enhance satiety signaling and gastric regulation • Serve as a synergistic agent in combination with GLP-1 analogs (e.g., Semaglutide) Its dual-receptor activity offers a unique platform for studying multi-hormonal modulation of metabolic pathways. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C in a dry, light-protected environment • Reconstitute with bacteriostatic water, acetic acid, or other suitable diluent • store in the refrigerator once a reconstituted solution to preserve bioactivity 2-8 °C
£80.00
Cagrilintide 10mg (Disposable pen)
🧬 Cagrilintide – Long-Acting Amylin Analog for Appetite Regulation & Weight Loss Research Synonyms: AM833, Long-Acting Amylin Receptor Agonist CAS Number: 1415456-99-3 Sequence: Modified 37-amino acid peptide with disulfide bridge Molecular Weight: ~4409.0 Da Form: Pre-filled 10mg injectable pen Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Cagrilintide is a synthetic, long-acting analog of amylin, a hormone co-secreted with insulin by pancreatic β-cells. It binds to amylin and calcitonin receptors in the brain, particularly in the area postrema and hypothalamus, where it modulates satiety, gastric emptying, and energy intake. The 10mg pre-filled pen format provides precise, once-weekly administration, ideal for long-term metabolic research protocols and combination studies with GLP-1 receptor agonists. --- ⚙️ Mechanism of Action: Cagrilintide mimics the physiological effects of endogenous amylin but with enhanced stability and extended half-life. It: • Promotes satiety by activating amylin receptors in the CNS • Slows gastric emptying, prolonging postprandial fullness • Reduces food intake without stimulating reward pathways • Suppresses glucagon secretion, contributing to glycemic control Its non-incretin mechanism makes it a valuable adjunct in multi-pathway metabolic research. --- 📈 Research Applications: Cagrilintide is under investigation in preclinical and clinical models for: • Obesity and appetite regulation • Type 2 diabetes and glycemic control • Combination therapy with GLP-1 agonists (e.g., semaglutide, tirzepatide) • Cardiometabolic risk reduction • Neuroendocrine signaling and satiety modeling In Phase 2 trials, Cagrilintide monotherapy achieved up to 10.8% body weight reduction over 26 weeks, with enhanced results when combined with semaglutide. --- 🧪 Dosing & Handling (Preclinical): • Formulation: 10mg pre-filled pen • Half-life: ~7–8 days (supports once-weekly administration) • Storage: Refrigerate at 2–8°C; protect from light • Administration: Subcutaneous injection; rotate sites weekly • Cycle: 12–24 weeks typical for metabolic remodeling studies --- 📦 Packaging & Storage: Supplied as a sterile, pre-filled 10mg pen for subcutaneous administration. Storage: Refrigerate at 2–8°C. Do not freeze. Use aseptic technique. For research use only.
£95.00
Tirzepatide 40mg (Disposable pen)
🧬 Tirzepatide – Dual GIP/GLP-1 Receptor Agonist for Metabolic Research Synonyms: LY3298176, Dual Incretin Analog CAS Number: 2023788-19-2 Sequence: 39-amino acid linear peptide with C20 fatty diacid moiety Molecular Weight: ~4813.5 Da Form: Pre-filled 40mg injectable pen Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Tirzepatide is a synthetic dual incretin receptor agonist that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual engagement enhances insulin secretion, reduces appetite, and improves metabolic flexibility. The 40mg pre-filled pen format provides high-dose, once-weekly delivery, ideal for advanced metabolic research protocols requiring sustained incretin exposure. --- ⚙️ Mechanism of Action: Tirzepatide mimics the body’s natural incretin response to nutrient intake: • GIPR Activation: Enhances insulin secretion, improves adipocyte insulin sensitivity, and increases adiponectin • GLP-1R Activation: Delays gastric emptying, suppresses appetite, and reduces glucagon secretion Together, these pathways produce synergistic effects on glucose regulation, body weight, and lipid metabolism—surpassing the efficacy of GLP-1 agonists alone. --- 📈 Research Applications: Tirzepatide is under investigation in preclinical and clinical models for: • Obesity and body composition modulation • Type 2 diabetes and insulin resistance • Non-alcoholic fatty liver disease (NAFLD) • Cardiometabolic risk reduction • Neuroendocrine signaling and appetite regulation In clinical trials, Tirzepatide has demonstrated up to 22.5% body weight reduction and superior glycemic control compared to semaglutide, with additional benefits in lipid and inflammatory markers. --- 🧪 Dosing & Handling (Preclinical): • Formulation: 40mg pre-filled pen • Half-life: ~5 days (supports once-weekly administration) • Storage: Refrigerate at 2–8°C; protect from light • Administration: Subcutaneous injection; rotate sites weekly • Cycle: 12–72 weeks typical for metabolic remodeling studies --- 📦 Packaging & Storage: Supplied as a sterile, pre-filled 40mg pen for subcutaneous administration. Store refrigerated 2–8°C. Do not freeze. Use aseptic technique. For research use only.
£145.00
Retatrutide 20mg (Disposable Pen)
🧬 Retatrutide – Triple Receptor Agonist for Advanced Metabolic Research Synonyms: LY3437943, GLP-1/GIP/Glucagon Triagonist CAS Number: 2381089-83-2 Sequence: 39-amino acid peptide (modified analog of oxyntomodulin) Molecular Weight: ~4867.3 Da Form: Pre-filled 20mg injectable pen Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Retatrutide is a next-generation triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. This multi-pathway engagement enables a synergistic effect on appetite suppression, energy expenditure, and glycemic control. The 20mg pre-filled pen format offers precise, ready-to-administer dosing, ideal for advanced metabolic research protocols requiring consistent delivery and elevated exposure. --- ⚙️ Mechanism of Action: Retatrutide mimics and amplifies the body’s natural incretin and glucagon signaling cascade: • GLP-1R Activation: Enhances insulin secretion, delays gastric emptying, and reduces appetite • GIPR Activation: Improves insulin sensitivity and β-cell function • GCGR Activation: Increases energy expenditure, promotes lipolysis, and reduces hepatic steatosis This triple-receptor synergy results in robust weight loss, improved glucose metabolism, and visceral fat reduction, making it a powerful scaffold for obesity and metabolic syndrome research. --- 📈 Research Applications: Retatrutide is under investigation in preclinical and clinical models for: • Obesity and body weight regulation • Type 2 diabetes and insulin resistance • Non-alcoholic fatty liver disease (NAFLD) • Cardiometabolic risk reduction • Combination therapy with amylin analogs (e.g., Cagrilintide) In Phase 2 trials, subjects receiving high-dose Retatrutide experienced up to 24.2% body weight reduction over 48 weeks, with favorable shifts in lipid and glycemic markers. --- 🧪 Dosing & Handling (Preclinical): • Formulation: 20mg pre-filled pen • Half-life: ~6–7 days (supports once-weekly administration) • Storage: Refrigerate at 2–8°C; protect from light • Administration: Subcutaneous injection; rotate sites to minimize irritation • Cycle: 12–24 weeks typical for metabolic remodeling studies --- 📦 Packaging & Handling: Supplied as a sterile, pre-filled 20mg pen for subcutaneous administration. Store refrigerated 2–8°C. Do not freeze. Use aseptic technique. For research use only.
£145.00
GHK-Cu 100mg (Lyophilized Vial)
🧬 GHK-Cu – Copper-Binding Tripeptide for Regenerative & Anti-Aging Research Synonyms: Glycyl-L-Histidyl-L-Lysine Copper Complex, Copper Tripeptide-1 CAS Number: 89030-95-5 Sequence: Gly-His-Lys·Cu²⁺ Molecular Weight: ~403.9 Da (complexed form) Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine, histidine, and lysine, complexed with a divalent copper ion (Cu²⁺). It is endogenously present in plasma, saliva, and urine, with levels declining significantly with age. GHK-Cu is under active investigation for its role in tissue remodeling, wound healing, angiogenesis, and anti-inflammatory signaling, making it a versatile scaffold in regenerative and dermatological research. --- ⚙️ Mechanism of Action: GHK-Cu exerts its biological effects through multiple converging pathways: • Collagen & ECM Remodeling: Stimulates synthesis of collagen, elastin, glycosaminoglycans, and decorin • Anti-Inflammatory Modulation: Downregulates pro-inflammatory cytokines (e.g., TNF-α, IL-6) • Angiogenesis Support: Provides bioavailable copper essential for vascular endothelial growth • Wound Healing: Enhances fibroblast activity and promotes scarless tissue regeneration • Neuroregeneration: Encourages axonal outgrowth and synaptic repair in neuronal models • DNA Repair & Epigenetic Resetting: Shown to influence gene expression linked to cellular rejuvenation Its ability to act as a tissue-specific signaling molecule makes it a compelling candidate in both cosmetic and therapeutic research domains. --- 📈 Research Applications: GHK-Cu is being explored in preclinical and in vitro models for: • Skin regeneration and anti-aging • Hair follicle stimulation and pigmentation • Wound healing and scar reduction • Neuroinflammation and nerve repair • Osteogenesis and bone remodeling • UV protection and photodamage mitigation Its non-hormonal, non-immunogenic profile makes it suitable for long-term regenerative studies. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide–metal complex • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water, saline, or appropriate buffer • Store in the refrigerator once in a reconstituted solution to preserve stability 2-8 °C
£45.00
BPC-157 20MG (Lyophilized Vial)
🧬 BPC-157 – Regenerative Peptide for Angiogenesis, Tissue Repair & Gastrointestinal Research Synonyms: Body Protection Compound-157, PL 14736 CAS Number: 137525-51-0 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight: ~1419.5 Da Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of Body Protection Compound (BPC), a protein naturally found in human gastric juice. It is under active investigation for its multifaceted regenerative properties, particularly in models of muscle, tendon, nerve, and gastrointestinal repair. BPC-157 is known to modulate angiogenesis, collagen synthesis, and inflammatory signaling, making it a versatile scaffold in wound healing and organoprotection research. --- ⚙️ Mechanism of Action: Although not fully elucidated, BPC-157 is believed to act through several converging pathways: • VEGF Upregulation: Promotes angiogenesis and microvascular repair • Fibroblast Activation: Enhances collagen production and extracellular matrix remodeling • Anti-Inflammatory Modulation: Downregulates pro-inflammatory cytokines (e.g., TNF-α, IL-6) • Neuroregeneration: Supports axonal outgrowth and synaptic repair in peripheral nerve models • Gastrointestinal Protection: Accelerates healing of ulcers and mitigates NSAID-induced mucosal damage Its systemic effects have been observed in both local injury models and systemic inflammatory conditions. --- 📈 Research Applications: BPC-157 is being explored in preclinical and in vitro models for: • Tendon-to-bone healing and ligament repair • Skeletal muscle regeneration and myocyte protection • Gastrointestinal mucosal healing (e.g., IBD, ulcers) • Peripheral nerve injury and neuroinflammation • Joint health and arthritis models • Angiogenesis and ischemic tissue recovery Its non-anabolic, non-hormonal profile makes it suitable for diverse regenerative studies without endocrine disruption. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water, acetic acid, or appropriate diluent • Store in the refrigerator once in a reconstituted solution to preserve bioactivity 2-8°C
£45.00
Melanotan 1
🧬 Melanotan 1 – Selective MC1R Agonist for Pigmentation Research Synonyms: Afamelanotide, [Nle⁴, D-Phe⁷]-α-MSH, CUV1647 CAS Number: 75921-69-6 Sequence: Ac-Ser-Tyr-Ser-Nle⁴-Glu-His-D-Phe⁷-Arg-Trp-Gly-Lys-Pro-Val-NH₂ Molecular Weight: ~1646.9 Da Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Melanotan 1 is a synthetic linear peptide analog of alpha-melanocyte-stimulating hormone (α-MSH), engineered to selectively activate the melanocortin 1 receptor (MC1R). This receptor is primarily expressed in melanocytes, where it regulates eumelanin production and UV-induced pigmentation. Melanotan 1 is structurally optimized for enhanced receptor affinity, proteolytic resistance, and prolonged biological activity, making it a valuable tool in pigmentation and photoprotection research. --- ⚙️ Mechanism of Action: Melanotan 1 binds with high specificity to MC1R, initiating a cAMP-mediated signaling cascade that: • Stimulates eumelanin synthesis via upregulation of tyrosinase and related enzymes • Enhances UV-induced pigmentation and melanocyte activation • May reduce UV-induced DNA damage by increasing melanin density Unlike Melanotan 2, MT-1 exhibits minimal off-target activity at MC3R and MC4R, reducing the likelihood of systemic or neuroendocrine effects in research models. --- 📈 Research Applications: Melanotan 1 is under investigation in preclinical and in vitro models for: • Skin pigmentation and photoprotection • Melanocyte biology and UV response • Eumelanin vs pheomelanin expression ratios • Potential synergy with UVB exposure in pigmentation studies Its receptor selectivity makes it ideal for targeted melanogenesis research without confounding systemic effects. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water, acetic acid, or other suitable diluent • Store in the refrigerator once a reconstituted solution to preserve integrity 2-8°C
£30.00
5-Amino-1MQ 10mg (Lyophilized Vial)
🧬 5-Amino-1MQ – NNMT Inhibitor for Metabolic and NAD⁺ Pathway Research Synonyms: 5-Amino-1-methylquinolinium, 5-Amino-1MQ CAS Number: 14003-96-4 Chemical Formula: C₁₀H₁₁N₂⁺ Molecular Weight: ~159.21 g/mol Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: 5-Amino-1MQ is a small-molecule compound designed to selectively inhibit nicotinamide N-methyltransferase (NNMT), an enzyme implicated in adipose tissue metabolism, NAD⁺ salvage pathways, and cellular energy regulation. By targeting NNMT, 5-Amino-1MQ has emerged as a promising research scaffold for exploring fat oxidation, muscle preservation, and metabolic reprogramming in preclinical models. --- ⚙️ Mechanism of Action: 5-Amino-1MQ functions as a selective NNMT inhibitor, leading to: • Increased NAD⁺ availability via reduced methylation of nicotinamide • Activation of SIRT1, a longevity-associated deacetylase • Enhanced AMPK signaling, promoting fatty acid oxidation and mitochondrial biogenesis • Reduced lipogenesis and adipocyte hypertrophy These pathways collectively support investigations into energy expenditure, insulin sensitivity, and body composition modulation A. --- 📈 Research Applications: 5-Amino-1MQ is under active investigation in models of: • Obesity and diet-induced adiposity • Type 2 diabetes and insulin resistance • Muscle regeneration and sarcopenia • NAD⁺ metabolism and cellular aging • Cancer metabolism and NNMT overexpression Its small-molecule structure allows for oral or injectable administration in animal studies, with favorable cellular permeability and bioavailability A. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized powder • Store at –20°C, protected from light and moisture • Reconstitute with DMSO, ethanol, or appropriate solvent for in vitro or in vivo use • Store on a refrigerator once in a reconstituted solution to maintain stability 2-8 °C
£55.00
L’Carnatine 500Mg/Ml
💧 L-Carnitine – Injectable Amino Acid Derivative for Fat Oxidation & Mitochondrial Research Synonyms: Levocarnitine, L-3-Hydroxy-4-trimethylaminobutyrate CAS Number: 541-15-1 Molecular Formula: C₇H₁₅NO₃ Molecular Weight: ~161.2 g/mol Form: Sterile injectable solution (commonly 500–600 mg/mL) Research Use Only. Not for human consumption. --- Description: L-Carnitine is a naturally occurring quaternary ammonium compound synthesized from lysine and methionine. It plays a critical role in fatty acid metabolism, acting as a shuttle that transports long-chain fatty acids across the mitochondrial membrane for β-oxidation. The injectable form bypasses gastrointestinal absorption, offering superior bioavailability and rapid systemic uptake, making it ideal for studies involving energy metabolism, endurance, and fat mobilization. --- ⚙️ Mechanism of Action: L-Carnitine facilitates the transport of fatty acids into the mitochondrial matrix by forming acyl-carnitine esters, enabling their conversion into ATP via oxidative phosphorylation. It also supports mitochondrial buffering, reduces acyl-CoA accumulation, and may enhance insulin sensitivity in skeletal muscle. In research models, it has been shown to increase VO₂ max, reduce fatigue, and improve recovery post-exercise. --- 📈 Research Applications: Injectable L-Carnitine is under investigation in preclinical and in vitro models for: • Fat oxidation and body composition modulation • Exercise performance and endurance enhancement • Mitochondrial biogenesis and metabolic flexibility • Neuroprotection and cognitive function • Cardiovascular and hepatic energy metabolism It is also frequently studied in stacked protocols with agents like AOD-9604, 5-Amino-1MQ, or Retatrutide to explore synergistic fat-loss and metabolic effects. --- 📦 Packaging & Handling: Supplied as a sterile aqueous solution, typically in 10–20 mL vials at 500mg/mL. Store at room temperature, protected from light. Once opened, refrigerate and use within 28 days. Administer via intramuscular (IM) or subcutaneous (SubQ) injection using aseptic technique.
£20.00
Tesamorelin 10mg (Lyophilized Vial)
🧬 Tesamorelin – Stabilized GHRH Analog for Endogenous GH Axis Modulation Synonyms: Egrifta, TH9507, Tesamorelin Acetate CAS Number: 218949-48-5 Sequence: C₂₂₁H₃₆₆N₇₂O₆₁S Molecular Weight: ~5135 Da Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Tesamorelin is a synthetic 44-amino acid peptide analog of growth hormone-releasing hormone (GHRH), engineered for enhanced stability and receptor affinity. It selectively binds to GHRH receptors (GHRHr) in the anterior pituitary, stimulating pulsatile release of endogenous growth hormone (GH). Unlike exogenous GH, Tesamorelin preserves physiological feedback loops, making it a valuable tool for studying GH axis modulation, lipid metabolism, and visceral adiposity. --- ⚙️ Mechanism of Action: Tesamorelin activates the hypothalamic-pituitary-GH axis by: • Binding to GHRH receptors in the pituitary • Stimulating somatotrophs to release GH in a natural rhythm • Elevating IGF-1 levels downstream, supporting anabolic and lipolytic effects • Preserving negative feedback regulation, reducing risk of GH desensitization This mechanism supports investigations into fat redistribution, muscle preservation, and neuroendocrine signaling. --- 📈 Research Applications: Tesamorelin is under investigation in preclinical and in vitro models for: • Visceral fat reduction and lipodystrophy modeling • Cognitive function and neuroprotection • Peripheral nerve regeneration • Age-related GH decline and metabolic dysfunction Its ability to restore youthful GH pulsatility without supraphysiologic exposure makes it ideal for longitudinal metabolic studies. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water or appropriate diluent • Store in the refrigerator once a reconstituted solution to preserve bioactivity 2-8°C
£60.00
Ipamorelin 10mg (Lyophilized Vial)
🧬 Ipamorelin – Selective Growth Hormone Secretagogue (GHS) Synonyms: NNC 26-0161 CAS Number: 170851-70-4 Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ Molecular Weight: ~711.9 Da Form: Lyophilized powder Purity: ≥98% (HPLC) Research Use Only. Not for human consumption. --- Description: Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist. It is designed to stimulate endogenous growth hormone (GH) release via activation of the GHS-R1a receptor, without significantly affecting cortisol, prolactin, or ACTH levels. This receptor selectivity makes Ipamorelin a valuable tool in research focused on anabolic signaling, tissue regeneration, and age-related GH decline. --- ⚙️ Mechanism of Action: Ipamorelin mimics the action of ghrelin, binding to the GHS-R1a receptor in the pituitary and hypothalamus to: • Stimulate GH release via somatotroph activation • Inhibit somatostatin, the natural GH suppressor • Avoid triggering the hypothalamic-pituitary-adrenal (HPA) axis, minimizing stress hormone elevation Its short half-life (~2 hours) and clean hormonal profile make it ideal for studying isolated GH effects in metabolic and regenerative models. --- 📈 Research Applications: Ipamorelin is under investigation in preclinical models for: • Muscle growth and recovery • Bone mineral density and osteogenesis • Fat metabolism and body composition • Anti-aging and GH axis modulation • Post-injury tissue repair Its favorable safety profile and receptor specificity distinguish it from earlier GHRPs like GHRP-6 or GHRP-2. --- 📦 Packaging & Handling: • Supplied as a sterile-filtered lyophilized peptide • Store at –20°C, protected from light and moisture • Reconstitute with bacteriostatic water or appropriate diluent • Store in the refrigerator once in a reconstituted solution to preserve bioactivity 2-8°C
£35.00
Bacteriostatic Water 0.9% (Liquid)
💧 Bacteriostatic Water – Sterile Diluent with Antimicrobial Preservative Synonyms: Bac Water, BW, Benzyl Alcohol Water CAS Number: 7732-18-5 (Water), 100-51-6 (Benzyl Alcohol) Composition: Sterile Water for Injection + 0.9% Benzyl Alcohol Form: Clear aqueous solution pH Range: 4.5–7.0 Research Use Only. Not for human consumption. --- Description: Bacteriostatic Water is a sterile, non-pyrogenic aqueous solution formulated with 0.9% benzyl alcohol as a preservative. It is specifically designed for reconstituting lyophilized peptides and other research compounds, offering extended usability and microbial resistance in multi-dose applications. The inclusion of benzyl alcohol inhibits bacterial growth, making it ideal for repeated withdrawals over a 28-day period under aseptic conditions. --- ⚙️ Functional Role: • Diluent for Peptide Reconstitution: Maintains sterility and solubility for injectable research compounds • Antimicrobial Action: Benzyl alcohol prevents microbial proliferation post-opening • Multi-Dose Compatibility: Suitable for repeated use without compromising sterility • Stability Enhancer: Helps preserve peptide integrity during refrigerated storage --- 📈 Research Applications: Bacteriostatic Water is widely used in: • Peptide and protein reconstitution • Hormone and analog dilution protocols • Multi-dose vial preparation • Preclinical formulation development Its preservative profile makes it preferable over sterile water for longitudinal studies and multi-use peptide vials. --- 📦 Packaging & Handling: • Supplied in 10ml sterile vials • Store at 20–25°C (68–77°F); refrigerate after opening 2-8°C • Discard within 28 days of first puncture • Use aseptic technique for all withdrawals
£10.00
Disposable Peptide Pen
Benefits of Using Disposable Injector Pens for Peptides Disposable injector pens offer a convenient, precise, and efficient method for administering peptide therapies. Designed with ease of use in mind, these pens simplify peptide delivery, making them ideal for both research applications and personal use. • Precision & Accuracy – Injector pens allow for highly controlled dosing, ensuring consistent administration without the variability of manual syringes. This is especially important when working with peptides that require exact measurements for optimal effectiveness. • Enhanced Sterility & Safety – Each disposable pen is prefilled and sealed, minimizing the risk of contamination. Since they are single-use, there’s no need for repeated handling or potential exposure to environmental contaminants. • Convenience & Ease of Use – Unlike traditional vials and syringes, injector pens streamline the process with a simple, push-button mechanism, reducing the likelihood of user error and making administration quick and hassle-free. • Reduced Waste & Cleanup – With preloaded formulations, there’s no need for additional mixing or preparation, and since the pen is discarded after use, there’s no concern over needle disposal or sterilization. • Portability & Discreet Application – Compact and lightweight, disposable injector pens are easy to transport and use on the go. They provide a discreet and efficient alternative for those who require peptide therapy without the bulk of traditional injections.
£8.00
Reusable Peptide Pen
Benefits of Using Reusable Injector Pens for Peptides Reusable injector pens provide a cost-effective, eco-friendly, and precise solution for administering peptide therapies. Designed for longevity and ease of use, they offer a reliable alternative to traditional injection methods while maintaining accuracy and convenience. • Cost-Effective & Sustainable – Unlike disposable pens, reusable models can be refilled multiple times, reducing overall costs and minimizing environmental waste. They offer long-term savings while maintaining efficiency. • Precision Dosing & Consistency – With adjustable settings, reusable pens ensure accurate dosage delivery, allowing users to fine-tune administration for optimal results. This is especially beneficial for peptides requiring precise measurements. • Sterility & Safety – While reusable, these pens are designed to maintain sterility with replaceable cartridges and needles, reducing the risk of contamination while ensuring proper hygiene with each use. • Ease of Use & Reduced Waste – Built for simplicity, reusable pens streamline the injection process with an intuitive mechanism while eliminating excessive packaging waste associated with single-use options. • Portability & Practicality – Compact and durable, reusable injector pens are ideal for on-the-go applications. Their sturdy design ensures longevity, making them a reliable choice for sustained peptide therapy.
£25.00
Schott 3ml Pen Cartridges x1
SCHOTT 3 mL pen cartridges, particularly those made from FIOLAX® Type I borosilicate glass, offer several advantages over standard 3 mL cartridges that can elevate both performance and perception: 1. Superior chemical resistance: FIOLAX® glass ensures excellent extractables and leachables profiles, which is crucial for maintaining drug stability—especially with sensitive peptides or biologics. 2. Tight dimensional no tolerances: SCHOTT cartridges undergo 100% camera inspection, resulting in highly consistent geometries. This improves compatibility with pen injectors and ensures smooth, reliable dosing. 3. Enhanced break resistance: Their Break Resistant (BR) variants are chemically toughened to withstand mechanical stress—ideal for emergency-use drugs or rugged handling environments. 4. Optimized for self-administration: These cartridges are designed for accurate, repeatable dosing in pen and auto-injector systems, making them ideal for hormone therapies, diabetes treatments, or research applications where precision matters. 5. High cosmetic quality: Especially in the TopLine series, SCHOTT offers cartridges with minimal visual defects—important for premium branding and user trust.
£3.00
Acetic acid 0.6%
💧 Acetic Acid – Dilute Solvent for Peptide Reconstitution & pH Adjustment Synonyms: Ethanoic Acid, Glacial Acetic Acid (diluted) CAS Number: 64-19-7 Concentration: 0.6%–1.0% aqueous solution (typical for peptide use) Form: Clear, sterile liquid Research Use Only. Not for human consumption. --- Description: Acetic Acid is a polar protic solvent widely used in peptide science to aid in the reconstitution of lyophilized peptides, particularly those with hydrophobic or acidic residues. When diluted to 0.6–1.0%, it serves as a pH-lowering agent that enhances solubility, disrupts peptide aggregation, and stabilizes delicate molecular conformations. It is especially useful for peptides like GHK-Cu, IGF variants, and long-chain metabolic analogs that resist dissolution in bacteriostatic water alone. --- ⚙️ Functional Role in Research: • Solubility Enhancer: Breaks hydrophobic interactions and peptide clumping • pH Modulator: Lowers solution pH to improve dissolution of acidic or amphipathic peptides • Stabilizer: Preserves peptide structure during reconstitution and short-term storage • Carrier Compatibility: Often used in combination with bacteriostatic water for dual-phase solubilization --- 📈 Research Applications: Acetic Acid is routinely used in: • Peptide reconstitution protocols for difficult-to-dissolve compounds • Metal-binding peptide studies, such as GHK-Cu or MOTS-c • pH-sensitive formulations requiring acidic environments • Analytical chemistry workflows, including HPLC and CE sample prep Its role is especially critical in preserving peptide integrity during the initial solubilization phase. --- 📦 Packaging & Handling: Supplied in sterile, sealed vials (typically 3ml or 10ml). Store at room temperature, away from light and moisture. Use aseptic technique when withdrawing. Discard within 28 days of opening if sterility is compromised.
£10.00
Sterile Water WFI 2ml x5
💧 Sterile Water for Injection (WFI) – Pyrogen-Free Solvent for Parenteral-Grade Reconstitution Synonyms: SWFI, Sterile WFI CAS Number: 7732-18-5 Form: Clear, sterile, non-pyrogenic aqueous solution pH Range: 5.0–7.0 Research Use Only. Not for human consumption. --- Description: Sterile Water for Injection (WFI) is a high-purity, pyrogen-free solvent specifically designed for parenteral-grade applications, including the reconstitution of lyophilized peptides, biologics, and injectable research compounds. It meets or exceeds USP, EP, and JP pharmacopoeial standards, ensuring the absence of endotoxins, microbial contaminants, and particulates. Unlike bacteriostatic water, WFI contains no preservatives, making it ideal for single-use, sterile environments where absolute purity is required. --- ⚙️ Functional Role in Research: • Solvent for Peptide Reconstitution: Ideal for peptides that are sensitive to preservatives or require neutral pH • Parenteral-Grade Purity: Free from endotoxins and microbial contaminants • Single-Use Applications: Preferred for sterile, one-time reconstitution protocols • Carrier for Dilution: Used in formulation of injectable research compounds and biologics --- 📈 Research Applications: Sterile WFI is widely used in: • Peptide and protein reconstitution • Cell culture and biologic formulation • Vaccine and mRNA research • Final rinse for sterile equipment and vials • Analytical chemistry workflows requiring pyrogen-free solvents Its non-reactive, preservative-free profile makes it suitable for sensitive peptides like IGF-1 variants, GHK-Cu, and neuropeptides. --- 📦 Packaging & Handling: Supplied in single-use sterile vials or ampoules. Store at 20–25°C, protected from light and contamination. Once opened, use immediately to maintain sterility. Do not reuse or store after puncture.
£10.00
Sales@biochem-peptides.co.uk
Telegram
TikTok
Disclaimer:
The supplier accepts no liability for improper use, misuse, or any consequences arising from the handling, application, or distribution of the products outside of their intended purpose. Customers are solely responsible for ensuring compliance with local regulations and guidelines regarding the purchase and use of research chemicals and peptides.
Any information provided on this website, including descriptions and references, is for educational and informational purposes only and should not be interpreted as guidance for usage beyond research applications.